Diagnosis of asbestos-related pleuropolmonary diseases

Medicina del Lavoro

Volumn 97, Issue 3, 2006, Pages 463-474

  Governa, M ^a   Amati, Monica ^a   Bellis, Donata ^b   Bichisecchi, Elisabetta ^c   Santarelli, Lory ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

Asbestosis; Interstitial fibrosis; Mesothelioma

Indexed keywords

ASBESTOS;

ASBESTOSIS; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG TUMOR; MESOTHELIOMA; PLEURA DISEASE; REVIEW;

ASBESTOS; ASBESTOSIS; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; PLEURAL DISEASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 38349112841     PISSN: 00257818     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (77)

1. ABERLE DR, CHILES C, GATSONIS C, et al: American College of Radiology Imaging Network: Imaging and cancer: research strategy of the American College of Radiology Imaging Network. Radiology 2005; 235: 741-751
2. AFELTRA A, CACCAVO D, FERRI GM, et al: Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies. Clin Exp Immunol 1997; 109: 279-285
3. AKIRA M, YAMAMOTO S, YOKOYAMA K, et al: Asbestosis: high-resolution CT-pathologic correlation. Radiology 1990; 176: 389-394
4. AMERICAN THORACIC SOCIETY: Medical Section of the American Lung Association: The diagnosis of nonmalignant diseases related to asbestos. Am Rev Respir Dis 1986; 134: 363-368
5. AMERICAN THORACIC SOCIETY: Diagnosis and initial management of non malignant diseases related to asbestos. Am J Respir Crit Care Med. 2004; 170 :691-715
6. ATTANOOS RL, GIBBS AR: Asbestos-related deaths. Current Diagnostic Pathology 2002; 8: 373-383
7. BARNETSON RJ, BURNETT RA, DOWNIE I, et al: Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful. Am J Clin Pathol 2006; 125: 67-76
8. BARTON JC, PARMLEY RT, BUTLER TW, et al: Differential staining of neutrophils and monocytes: surface and cytoplasmic iron-binding proteins. Histochem J 1988; 20: 147-155
9. BELLIS D, ANDRION A, DELSEDIME L, MOLLO F: Minimal pathologic changes of the lung and asbestos exposure. Hum Pathol. 1989; 20: 102-106
10. BELLUSO E, BELLIS D, FORNERO S, et al: Assessment of the burden of inorganic fibres on biological samples by SEM-EDS. Microchimica Acta, 2006; 000: 1-6, in stampa
11. BERGIN R, OSTIGUY G, COMAN N, BERTRAN P: Computed tomography in the early detection of asbestosis. Br J Ind Med 1993; 50: 689-698
12. BETTA PG, ANDRION A, DONNA A, et al: Malignant mesothelioma of the pleura. The reproducibility of the immunohistological diagnosis. Pathol Res Pract 1997; 193: 759-765
13. BUCK AK, HALTER G, SCHIRRMEISTER H, et al: Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. J Nucl Med 2003; 44:1426-1431
14. CHAPMAN SJ, COOKSON WO, MUSK AW, LEE YC: Benign asbestos pleural diseases. Curr Opin Pulm Med 2003; 9: 266-271
15. CHURG A, GREEN FHY: Pathology of Occupational Lung Disease, second ed. Baltimore: Williams & Wilkins, 1998
16. CHURG A, COLBY TV, CAGLE P, et al: The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol. 2000; 24: 1183-1200
17. CHURG A: Pleural pathology. Pathology International 2004; 54: S490-S505
18. COMIN CE, NOVELLI L, BODDI V, et al: Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma. Hum Pathol 2001; 32: 529-536
19. CONSENSUS REPORT: Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health 1997; 23: 311-316
20. CONSENSUS REPORT: Elaboration of a clinical surveillance strategy for persons exposed to asbestos Rev Pneumol Clin 1999; 55:237-244
21. CRAIGHEAD JE, ABRAHAM JL, CHURG A, et al: The pathology of asbestos-associated diseases: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med 1982; 106: 544-586
22. DODSON RF, ATKINSON MA, O'SULLIVAN M: Stability of ferruginous bodies in human lung tissue following death, embalmment, and burial. Inhal Toxicol 2005; 17: 789-795
23. DORGER M, ALLMELIN GAM, KIEFMANN R, et al: Early inflammatory response to asbestos exposure in rat and hamster lungs: role of inducible nitric oxide synthase. Toxicol Appl Pharmacol 2002 1; 181: 93-105
24. DRISCOLL KE, MAURER JK, HIGGINS J, POYNTER J: Alveolar macrophage cytokine and growth factor production in a rat model of crocidolite-induced pulmonary inflammation and fibrosis. J Toxicol Environ Health. 1995; 46: 155-169
25. GHIO AJ, CHURG A, ROGGLI VL: Ferruginous bodies: implications in the mechanism of fiber and particle toxicity. Toxicol Pathol 2004; 32: 643-649
26. GIBBS GW: Biological indicators and their clinical significance in persons exposed to mineral fibres: report of a workshop held in Japan, 24-25 November 1991. Br J Ind Med 1993; 50: 412-417
27. GONZALEZ-LOIS C, BALLESTIN C, SOTELO MT, et al: Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura. Histopathology 2001; 38: 528-534
28. GORDON GJ: Transcriptional profiling of mesothelioma using microarrays. Lung Cancer 2005; 4951: S99-S103
29. GOVERNA M, AMATI M, FONTANA S, et al: Role of iron in asbestos-body-induced oxidant radical generation. J Toxicol Environ Health A 1999; 58: 279-287
30. GOVERNA M, AMATI M, VALENTINO M, et al: In vitro cleavage by asbestos fibers of the fifth component of human complement through free-radical generation and kallikrein activation. J Toxicol Environ Health 2000; 59: 539-552
31. GREEN FH, HARLEY R, VALLYATHAN V, et al: Exposure and mineralogical correlates of pulmonary fibrosis in chrysotile asbestos workers. Occup Environ Med 1997; 54: 549-559
32. GRENIER P, VALEYRE D, CLUZEL P, et al: Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high-resolution CT. Radiology 1991; 179: 123-132
33. HANSELL DM, KERR IH: The role of high resolution computed tomography in the diagnosis of interstitial lung disease. Thorax. 1991; 46: 77-84
34. HARARI S, CAMINATI A: Idiopathic pulmonary fibrosis. Allergy 2005; 60: 421-435
35. HILLERDAL G: Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study. Chest 1994; 105: 144-150
36. HILLERDAL G, HENDERSON DW: Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health 1997; 23: 93-103
37. HUGGINS JT, SAHN SA: Causes and management of pleural fibrosis. Respirology 2004; 9: 441-447
38. HUUSKONEN O, KIVISAARI L, ZITTING A, et al: High-resolution computed tomography classification of lung fibrosis for patients with asbestos-related disease. Scand J Work Environ Health. 2001; 27: 106-112
39. JOLY N, PAIRON JC, LETOURNEUX M, et al: Comparison of postero-anterior chest X-ray and high resolution computed tomography for the diagnosis of benign asbestos-related diseases. Arch Malad Prof 1998; 59: 7-12
40. KAMP DW, WEITZMAN SA: The molecular basis of asbestos induced lung injury. Thorax 1999; 54: 638-652
41. KING JE, THATCHER N, PICKERING CA, HASLETON PS: Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data. Histopathology 2006; 48: 223-232
42. KIPEN HM, LILIS R, SUZUKI Y, et al: Pulmonary fibrosis in asbestos insulation workers with lung cancer: a radiological and histopathological evaluation. Br J Ind Med 1987; 44: 96-100
43. KOBASHI Y, MATSUSHIMA T, IREI T: Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma. Respirology 2005; 10: 660-665
44. KRAUS T, RAITHED HJ, LEHNERT G: Computer-assisted classification system for chest X-ray and computed tomography findings in occupational lung disease. Int Arch Occup Environ Health 1997; 69: 482-486
45. LUND LG, WILLIAMS MG, DODSON RF, AUST AE: Iron Associated with asbestos bodies is responsible for the formation of single strand breaks in phi X174 RFI DNA. Occup Environ Med 1994; 51: 200-204
46. MAYO JR, WEBB WR, GOULD R, et al: High-resolution CT of the lungs: an optimal approach. Radiology 1987; 163: 507-510
47. MERCHANT RK, PETERSON MW, HUNNINGHAKE GW: Silica directly increases permeability of alveolar epithelial cells. J Appl Physiol 1990; 68: 1354-1359
48. MOHR S, BOTTIN MC, LANNES B, et al: Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells. Biochimie. 2004; 86:13-19
49. MOLLO F, BELLIS D: Implicazioni medico-legali della diagnosi di mesotelioma. In L'amianto: dall'ambiente di lavoro all'ambiente di vita. Nuovi indicatori per futuri effetti. Pavia: Fondazione Salvatore Maugeri, IRCSS, 1997: I documenti, 12: 254-260
50. MOLLO F, CRAVELLO M, ANDREOZZI A, et al: Asbestos body burden in decomposed human lungs. Am J Forensic Med Pathol 2000; 21: 148-150
51. MORGAN A, HOLMES A: the enigmatic asbestos body: its formation and significance in asbestos-related disease. Environ Res 1985; 38: 283-292
52. MULLER NL, STAPLES CA, MILLER RR, et al: Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology. 1987; 165: 731-734
53. MULLER NL, MILLER RR: Computed tomography of chronic diffuse infiltrative lung disease. Part 1. Am Rev Respir Dis 1990; 142:1206-1215
54. MULLER NL, MILLER RR: Computed tomography of chronic diffuse infiltrative lung disease. Part 2. Am Rev Respir Dis 1990; 142: 1440-1448
55. MURRAY KA, GAMSU G, WEBB WR, et al: High-resolution computed tomography sampling for detection of asbestos-related lung disease. Acad Radiol 1995; 2: 111-115
56. MUTSAERS SE, PRELE CM, BRODY AR, IDELL S: Pathogenesis of pleural fibrosis. Respirology 2004; 9: 428-440
57. NERI S, BORASCHI P, ANTONELLI A, et al: Pulmonary function, smoking habits, and high resolution computed tomography (HRCT) early abnormalities of lung and pleural fibrosis in shipyard workers exposed to asbestos. Am J Ind Med 1996; 30: 588-595
58. OKSA P, SUORANTA H, KOSKINEN H, et al: High-resolution computed tomography in the early detection of asbestosis. Int Arch Occup Environ Health 1994; 65: 299-304
59. ORDONEZ NG: D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol 2005; 36:372-380
60. PARIS C, BENICHOU J, RAFFAELLI C, et al: Factors associated with early-stage pulmonary fibrosis as determined by high-resolution computed tomography among persons occupationally exposed to asbestos. Scand J Work Environ Health 2004; 30: 206-214
61. PEACOCK C, COPLEY SJ, HANSELL DM: Asbestos-related benign pleural disease. Clinical Radiology 2000; 55: 422-432
62. PIRA E, DETRAGIACHE E, DISCALZI G, e coli: Linee guida per la sorveglianza sanitaria degli esposti ad agenti cancerogeni e mutageni in ambiente di lavoro. In Apostoli P, Imbriani M, Soleo L, et al (eds): Linee guida per laformazione continua e l'accreditamento del medico del lavoro. Pavia: Pime, 2003
63. QUINLAN TR, BERUBE KA, MARSH JP, et al: Patterns of inflammation, cell proliferation, and related gene expression in lung after inhalation of chrysotile asbestos. Am J Pathol. 1995; 147: 728-739
64. QUINLAN TR, BERUBE KA, HACKER MP, et al: Mechanisms of asbestos-induced nitric-oxide production by rat alveolar macrophages in inhalation and in vitro models. Free Radic Biol Med 1998; 15: 778-788
65. ROCKOFF SD, SCHWARTZ A: Roentgenographs underestimation of early asbestosis by International Labor Organization classification. Analysis of data and probabilities. Chest 1988; 93:1088-1091
66. ROGGLI VL, PRATT PC: Numbers of asbestos bodies on iron-stained tissue sections in relation to asbestos body counts in lung tissue digests. Hum Pathol 1983; 14: 355-361
67. SAMUEL P, HAMMAR MD: Macroscopic, histologic, histochemical. immunohistochemical and ultrastructural features of mesothelioma. Society of Ultrastructural Pathology Companion Meeting. February 27, 2005
68. SEGAL A, WHITAKER D, HENDERSON D, SHILKIN K: Pthology of mesothelioma. In Robinson BWS, Chahinian AP (eds): Mesothelioma. London: Martin Dunitz, 2002
69. SMITH DD: Plaques, cancer, and confusion. Chest 1994; 105: 8-9
70. SOOMRO IN, OLIVEIRA R, RONAN J, et al: Expression of mesothelial markers in malignant mesotheliomas: an immunohistochemical evaluation of 173 cases. J Pak Med Assoc 2005; 55:205-209
71. STAPLES CA, GAMSU G, RAY CS, WEBB WR: High resolution computed tomography and lung function in asbestos-exposed workers with normal chest radiographs. Am Rev Respir Dis 1989; 139: 1502-1508
72. SUSTER S, MORAN C: Malignant mesothelioma: current status of histopathologic diagnosis and molecular profile. Expert Rev Mol Diagn 2005; 5: 715-723
73. THOMAS G, ANDO T, VERMA K, KAGAN E: Asbestos fibers and interferon-gamma up-regulate nitric oxide production in rat alveolar macrophages. Am J Respir Cell Mol Biol 1994; 11: 707-715
74. WALCHLI P, RAJOWER I, CHRISTEN B, et al: Ferruginous bodies in lung dust as indicators of damage caused by asbestosis Pathologe 1987; 8: 346-350
75. WEBB WR, MULLER NL, NAIDICH DP: Asbestosis and asbestos related disease. In High resolution CT of the lung. Lippincott Williams & Wilkins 2001: 236-251
76. WRIGHT JL, CAGLE P, CHURG A, et al: Diseases of the small airways. Am Rev Respir Dis 1992; 146: 240-262
77. YAZIJI H, BATTIFORA H, BARRY TS, et al: Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-' antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol 2006; 19: 514-523